The liver in times of COVID-19: What hepatologists should know
Non-conventional
in English
| WHO COVID | ID: covidwho-291329
ABSTRACT
ABSTRACT The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic.
Search on Google
Collection:
Databases of international organizations
Database:
WHO COVID
Type of study:
Prognostic study
Language:
English
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS